Biofrontera (BFRI) Gains from Sales and Divestitures (2022 - 2025)
Biofrontera (BFRI) recorded quarterly Gains from Sales and Divestitures of $225000.0 in Q4 2025, little changed quarter-over-quarter from $225000.0 in Q3 2025, and up 4615.99% on a YoY basis from $4771.0 in Q4 2024.
Biofrontera (BFRI) Gains from Sales and Divestitures (2022 - 2025) Analysis & Trends
Biofrontera's Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $225000.0 for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures rose 4615.99% year-over-year to $225000.0; the TTM figure through Dec 2025 stood at $225000.0 (up 4615.99% YoY), while the FY2025 annual figure was $225000.0, up 4615.99% from the prior year.
- Gains from Sales and Divestitures was $225000.0 for Q4 2025 at Biofrontera, roughly flat from $225000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $170.1 million in Q2 2022 to a low of $4771.0 in Q2 2024.
- Historically, Gains from Sales and Divestitures has averaged $17.1 million across 4 years, with a median of $8588.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Gains from Sales and Divestitures sank 94.95% in 2023, then jumped 4615.99% in 2025.
- A 4-year view of Gains from Sales and Divestitures shows it stood at $8504.0 in 2022, then advanced by 0.99% to $8588.0 in 2023, then sank by 44.45% to $4771.0 in 2024, then surged by 4615.99% to $225000.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $225000.0 (Q4 2025), $225000.0 (Q3 2025), and $4771.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 225,000.00 |
| Dec 31, 2025 | 225,000.00 |
| Sep 30, 2025 | 225,000.00 |
| Sep 30, 2025 | 225,000.00 |
| Dec 31, 2024 | 4,771.00 |
| Dec 31, 2024 | 4,771.00 |
| Sep 30, 2024 | 4,771.00 |
| Sep 30, 2024 | 4,771.00 |
| Jun 30, 2024 | 4,771.00 |
| Jun 30, 2024 | 4,771.00 |
| Dec 31, 2023 | 8,588.00 |
| Dec 31, 2023 | 8,588.00 |
| Sep 30, 2023 | 8,588.00 |
| Sep 30, 2023 | 8,588.00 |
| Dec 31, 2022 | 8,504.00 |
| Dec 31, 2022 | 8,504.00 |
| Sep 30, 2022 | 170,068.00 |
| Sep 30, 2022 | 170,068.00 |
| Jun 30, 2022 | 170.07 Mn |
| Jun 30, 2022 | 170.07 Mn |